In 2023, Adam S. Grossman earned $4.16M in total compensation at ADMA Biologics, including $750.00K salary, $793.13K bonus and $2.57M in stock. 9+ years at the helm of ADMA Biologics.
Compensation History
Annual executive compensation data for Adam S. Grossman, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$4.16M
Salary
$750.00K
Bonus
$793.13K
Other
$46.80K
Salary
$750.00KBoard Justification
The compensation aligns with company performance, peer benchmarking, and retention strategies, with a focus on attracting and retaining top talent.
Bonus
$793.13KBoard Justification
Annual cash bonuses based on performance milestones and objectives established by the Board, paid in March 2024.
Other Compensation
$46.80KBoard Justification
Includes employer contributions to 401(k) plan and medical benefits paid by the Company.
Restricted Stock
Board Justification
RSUs granted on March 6, 2023, vesting quarterly over four years, subject to continued service.
Performance Metrics
Performance metrics include achievement of specific financial and operational goals set by the Board.
Adam S. Grossman
CEO of ADMA Biologics
Field of Expertise
Business & Management
Sector of Economy
Healthcare
CEO of ADMA Biologics for
9 years 6 months (Jun 2016 - Present)
Previous Experience
Unknown
Holdings
Track Adam S. Grossman's stock holdings and portfolio value over time.
Insider Trading
Adam S. Grossman's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Adam S. Grossman with competitor CEOs and industry peers.